罗欣药业：2025年上半年净利润1769.5万元，同比增长119.95%

Group 1 - The core viewpoint of the announcement indicates that the company experienced a decline in revenue for the first half of 2025, with a reported revenue of 1.077 billion yuan, representing a year-on-year decrease of 14.45% [1] - Despite the drop in revenue, the company achieved a net profit of 17.695 million yuan, which marks a significant year-on-year increase of 119.95% [1]